This paper presents a systematic parameter extraction method for an HBT temperature-dependant equivalent-circuit DC model. A reliable procedure was developed for determining the HBT thermal resistance, requiring only forward Gummel data at different temperatures and collector-emitter bias voltages. The extraction method was applied to predict the DC characteristics of a 2x25 μm emitter-area InG...

Triplet emitter materials present attractive possibilities for optimizations of organic/organometallic light emitting diodes (OLEDs). This is due to the significantly higher efficiencies obtainable with these compounds as compared to organic emitters. In this contribution, first a schematic introduction is given, how an OLED device is built-up and why multi-layer structures are preferred. Then ...

Background and Objective: The most common intravascular brachytherapy sources include 32P, 188Re, 106Rh and 90Sr/90Y. In this research, skin absorbed dose for different covering materials in dealing with these sources were evaluated and the best covering material for skin protection and reduction of absorbed dose by radiation staff was recognized and recommended.Method: Four materials including...

Ramsey's method of separated oscillatory fields is applied to the excitation of the cyclotron motion of short-lived ions in a Penning trap to improve the precision of their measured mass values. The theoretical description of the extracted ion-cyclotron-resonance line shape is derived and its correctness demonstrated experimentally by measuring the mass of the short-lived 38Ca nuclide with an u...

BEBIG Ruthenium-106 ophthalmic plaques have been used for treatment of uveal melanoma, retinoblastoma, melanoma of the iris and other special applications for many years. The plaques consist of a thin film of Ru, a beta emitter, encapsulated in pure silver. The present work proposes a new mathematical eye model for ophthalmic brachytherapy dosimetry. This new model includes detailed description...

One of the current therapeutic approaches in the treatment of osteoblastic bone metastases uses the affinity of Samarium ((153)Sm) ethylene-diamine-tetramethylene phosphonic acid (EDTMP) for bone areas of bone turnover. As Samarium EDTMP is a beta-emitter, the radiotherapy contributes to osteoblastic bone lesion control over time. To date, the safety and effectiveness of Samarium therapy have n...